Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU industry scrutinises US trade countermeasures:

This article was originally published in Clinica

Executive Summary

At face value, it does not appear that medical devices and diagnostics will be impacted by the EU/US dispute over the US legislation on foreign sales corporations. But close scrutiny of the implications of this dispute for the medical devices sector is needed. As part of the EU countermeasures against the US legislation, the EU has published a list of tariffs on imports from the US of certain goods from the US, which could increase costs of products by up to 100%. But the European medical devices industry association is asking its members to check closely that the materials they use in their products are not covered and is offering to lobby for the removal of any of these products/materials from the list if necessary.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT068288

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel